Literature DB >> 11727590

A review and analysis of the clinical- and cost-effectiveness studies of comprehensive health promotion and disease management programs at the worksite: 1998-2000 update.

K R Pelletier1.   

Abstract

PURPOSE: This article is the fifth in a series of critical reviews of the clinical effectiveness and cost-effectiveness studies of comprehensive, multifactorial health promotion and disease management programs conducted in worksites. As with the previous reviews, the purpose of this article is to review and assess the randomized control trials that have focused on both clinical and cost outcomes of worksite health promotion and disease management programs. For this current review, a new category of quasi-experimental studies has been added because this represents a major new trend in such interventions over the last 2 years. Comprehensive worksite programs are those that provide an ongoing, integrated program of health promotion and disease prevention that integrates specific components into a coherent, ongoing program that is consistent with corporate objectives and includes program evaluations of both clinical and cost outcomes. DATA SOURCES: A comprehensive search was conducted using a multistage process that included MEDLINE, ERIC, ADI, EDGAR, CARL, Inform, and Lexis-Nexis databases and direct inquiries to worksite researchers. INCLUSION AND EXCLUSION CRITERIA: The search identified 27 new studies to which the following inclusion criteria were applied: research conducted in the United States; results published in English; methodological quality of nonexperimental (pre- and postmeasures but no comparison group); quasi-experimental to randomized control trials; and both clinical and cost outcomes. Exclusion criteria were studies outside of the United States; non-English publications; and clinical or cost outcomes only. Fifteen studies remained for this review. FINDINGS EXTRACTION
METHODS: Findings extraction and analysis of the 15 studies was done by extracting the relevant population, intervention design, clinical results, and cost outcomes from the published article. As in previous reviews, findings are summarized in a table format that extracts and describes each study by the following: (1) study author(s); (2) corporate site; (3) purpose of the evaluation; (4) employee population; (5) percentage of program participants; (6) number of employees included in the evaluation; (7) brief description of the intervention; (8) evaluation design; (9) evaluation period; (10) outcomes; (11) research rating; and (12) findings. FINDINGS SYNTHESIS: Based on these 15 studies, a methodological critique was conducted with brief reference to appropriate prior studies. Conclusions regarding study quality and new trends over the time period of 1998 to 2000 are discussed. MAJOR
CONCLUSIONS: Results from randomized clinical trials and quasi-experimental designs suggest that providing individualized risk reduction for high risk employees within the context of comprehensive programming is the critical element of worksite interventions. Despite the many limitations of the current methodologies of the 15 new studies, the vast majority of the research to date indicates positive clinical and cost outcomes.

Entities:  

Mesh:

Year:  2001        PMID: 11727590     DOI: 10.4278/0890-1171-16.2.107

Source DB:  PubMed          Journal:  Am J Health Promot        ISSN: 0890-1171


  29 in total

Review 1.  Reducing social disparities in tobacco use: a social-contextual model for reducing tobacco use among blue-collar workers.

Authors:  Glorian Sorensen; Elizabeth Barbeau; Mary Kay Hunt; Karen Emmons
Journal:  Am J Public Health       Date:  2004-02       Impact factor: 9.308

2.  Preventing eye injuries among citrus harvesters: the community health worker model.

Authors:  Paul F Monaghan; Linda S Forst; Jose Antonio Tovar-Aguilar; Carol A Bryant; Glenn D Israel; Sebastian Galindo-Gonzalez; Zachary Thompson; Yiliang Zhu; Robert J McDermott
Journal:  Am J Public Health       Date:  2011-10-20       Impact factor: 9.308

3.  In defense of the randomized controlled trial for health promotion research.

Authors:  Laura Rosen; Orly Manor; Dan Engelhard; David Zucker
Journal:  Am J Public Health       Date:  2006-05-30       Impact factor: 9.308

4.  Tai Chi for older nurses: a workplace wellness pilot study.

Authors:  Mary Val Palumbo; Ge Wu; Hollie Shaner-McRae; Betty Rambur; Barbara McIntosh
Journal:  Appl Nurs Res       Date:  2010-04-13       Impact factor: 2.257

5.  The impact of comorbidity of mental and physical conditions on role disability in the US adult household population.

Authors:  Kathleen R Merikangas; Minnie Ames; Lihong Cui; Paul E Stang; T Bedirhan Ustun; Michael Von Korff; Ronald C Kessler
Journal:  Arch Gen Psychiatry       Date:  2007-10

Review 6.  Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators.

Authors:  Bruce S McEwen
Journal:  Eur J Pharmacol       Date:  2008-01-30       Impact factor: 4.432

Review 7.  Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease.

Authors:  Bruce S McEwen; Peter J Gianaros
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

8.  A pilot study of an online workplace nutrition program: the value of participant input in program development.

Authors:  Tara Cousineau; Brian Houle; Jonas Bromberg; Kathrine C Fernandez; Whitney C Kling
Journal:  J Nutr Educ Behav       Date:  2008 May-Jun       Impact factor: 3.045

9.  Successful reach and adoption of a workplace health promotion RCT targeting a group of high-risk workers.

Authors:  Marie B Jørgensen; Charlotte D N Rasmussen; Dorte Ekner; Karen Søgaard
Journal:  BMC Med Res Methodol       Date:  2010-06-14       Impact factor: 4.615

Review 10.  Economic evaluation and transferability of physical activity programmes in primary prevention: a systematic review.

Authors:  Silke B Wolfenstetter; Christina M Wenig
Journal:  Int J Environ Res Public Health       Date:  2010-04-09       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.